Breast Cancer Drug Launched To Help Women Who Have Stopped Responding To Herceptin | HuffPost Life

Breast Cancer Drug Launched To Help Women Who Have Stopped Responding To Herceptin

PA/The Huffington Post UK

A breast cancer drug for women who have stopped responding to Herceptin has been launched in the UK.

Kadcyla - also called T-DM1 - is given to patients who have failed on conventional treatment with Herceptin and chemotherapy.

It is only suitable for patients with the defective Her2 gene and trial results have shown it can extend life by six months compared with treatment with two other drugs, lapatinib (Tyverb) and capecitabine (a type of chemotherapy).

Kadcyla is designed to penetrate cancer cells and destroy them from within and, because its action is so precise, a normally toxic form of chemotherapy can be used.

Clinical trial results have shown that women on Kadcyla survived 30.9 months compared with 25.1 months for patients treated with lapatinib and capecitabine.

They also suffered fewer side-effects such as diarrhoea and vomiting.

Kadcyla is an antibody-drug conjugate which means it uses a "stable linker" to join Herceptin and a powerful chemotherapy together.

This enables a two-stage attack on cancer cells. Kadcyla blocks the growth signals that enable cancer cells to survive before releasing chemotherapy directly into the cells.

Story continues below the slideshow:

10 New Breast Cancer Findings

There Are 4 Major Classes Of Breast Cancer(01 of10)

Results of a massive gene analysis, published last month in the journal Nature, shows that there are four major classes of breast cancer, the Associated Press reported. "With this study, we're one giant step closer to understanding the genetic origins of the four major subtypes of breast cancer," study researcher Matthew Ellis, M.B., B.Chir., Ph.D., of the Washington University School of Medicine and the Siteman Cancer Center, said in a statement. "Now, we can investigate which drugs work best for patients based on the genetic profiles of their tumors," he added in the statement. "For basal-like breast tumors, it's clear they are genetically more similar to ovarian tumors than to other breast cancers. Whether they can be treated the same way is an intriguing possibility that needs to be explored."

Men With Breast Cancer Fare Worse(02 of10)

Men are less likely to get breast cancer than women -- but when they do, it's often deadlier, according to a study presented earlier this year at the American Society of Breast Surgeons meeting. The Associated Press reported that men diagnosed with breast cancer live, on average, two fewer years than women who are diagnosed with breast cancer, and are also more likely to have the breast cancer spread, have larger tumors when the cancer is discovered, and be diagnosed later. (credit:Alamy)

Cadmium Could Raise Breast Cancer Risk(03 of10)

Cadmium -- a toxic metal that can be present in foods like shellfish, root vegetables, offal and cereals -- may raise risk of breast cancer, according to a March 2012 study in the journal Cancer Research. The research included 56,000 women. Researchers were able to analyze about how much cadmium each woman was consuming based on the cadmium-rich foods in her diet. They found that those who consumed the most cadmium had a 21 percent higher breast cancer risk, compared with those who consumed the least cadmium, HuffPost's Catherine Pearson reported. (credit:Alamy)

Sleep May Affect Breast Cancer Risk (04 of10)

Getting six or fewer hours of sleep may raise the risk of recurrent breast cancer among post-menopausal breast cancer patients, according to a study in the journal Breast Cancer Research and Treatment. However, this same link was not observed for pre-menopausal breast cancer patients.The findings suggest "that lack of sufficient sleep may cause more aggressive tumors, but more research will need to be done to verify this finding and understand the causes of this association," study researcher Cheryl Thompson, Ph.D. said in the statement. (credit:Alamy)

A Smallpox Virus Could Be A Promising Treatment(05 of10)

A smallpox virus seems to be promising against a hard-to-treat form of breast cancer, called triple-negative breast cancer, according to a study in mice presented at the 2012 Annual Clinical Congress of the American College of Surgeons."Based upon pathology, we could see that at least 60 percent of the tumors were completely regressed and the other 40 percent had very little areas of tumor cells present with a lot of necrosis, which is a sign that the tumor was responding to therapy," study researcher Dr. Sepideh Gholami, M.D., of Stanford University Medical Center, said in a statement. ABC News pointed out that this kind of breast cancer is notoriously hard to treat because it doesn't respond to other hormonal or immune treatments. (credit:Alamy)

Shift Work May Influence Breast Cancer Risk(06 of10)

Working the night shift is linked to an increased risk of breast cancer, according to two different studies that came out this year.One of them, published in the journal Occupational and Environmental Medicine, showed that breast cancer risk went up among women who worked the night shift more than twice a week, with the risk being the highest among those who said that they are "morning people" instead of "night people." The Toronto Sun reported that the results of this study confirm the findings of the International Agency for Research on Cancer, which has a list of items and habits that may cause cancer. The IARC considers shift work "possibly carcinogenic."The other study, published in the International Journal of Cancer, showed that breast cancer risk is 30 percent higher for women who work the night shift, with the risk being especially clear among those working night-time jobs for four years, or those who worked the night shift for three or fewer nights a week. (credit:Alamy)

Breast Size May Be Linked With Breast Cancer Risk(07 of10)

The genes that help determine a woman's breast size may also be linked with her breast cancer risk, according to a study published earlier this year in the journal BMC Medical Genetics.Researchers examined the genetic data of 16,000 women to find that seven DNA variations, called single nucleotide polymorphisms (SNPs), seem to be linked with breast size -- and three of those SNPs are known to be associated with a person's risk of breast cancer, HuffPost's Catherine Pearson reported. (credit:Alamy)

Exercise Could Help Lower Breast Cancer Risk(08 of10)

Just a little bit of exercise may help to reduce your risk of breast cancer, though the more you move, the better, according to a study in the journal CANCER. Researchers at the University of North Carolina in Chapel Hill found that postmenopausal or reproductive-age women in their study who exercised the most -- from 10 to 19 hours each week -- had a 30 percent lower risk of breast cancer, though exercising less than that was still linked with some protective benefits. "The observation of a reduced risk of breast cancer for women who engaged in exercise after menopause is particularly encouraging given the late age of onset for breast cancer," study researcher Lauren McCullough said in a statement.

Type 2 Diabetes May Raise Breast Cancer Risk (For Some Women)(09 of10)

For post-menopausal women, having Type 2 diabetes may raise the risk of breast cancer, according to a review conducted by the International Prevention Research Institute. "On the one hand, it's thought that being overweight, often associated with Type 2 diabetes, and the effect this has on hormone activity may be partly responsible for the processes that lead to cancer growth," study researcher Peter Boyle, the president of the International Prevention Research Institute, told The Telegraph. "But it's also impossible to rule out that some factors related to diabetes may be involved in the process." (credit:Alamy)

Being Overweight Tied To Worst Breast Cancer Outcomes(10 of10)

Being overweight could lead to worse outcomes from breast cancer, according to a study published August in the journal Cancer. Specifically, the study showed that overweight women who have been treated for breast cancer have a higher risk of recurrence and death, NBC News reported."Obesity seemed to carry a higher risk of breast cancer recurrence and death -- even in women who were healthy at the time that they were diagnosed, and despite the fact that they received the best available chemotherapy and hormone therapy," study researcher Dr. Joseph Sparano, associate chairman of medical oncology at the Montefiore Einstein Center for Cancer Care, told NBC News. (credit:Alamy)

Kadcyla is administered intravenously once every three weeks.

The drug has not been appraised for use on the NHS by the National Institute for Health and Care Excellence (Nice).

Doctors can apply for treatment for suitable patients through the NHS cancer drugs fund and it is available privately.

Breakthrough Breast Cancer's senior policy manager, Dr Caitlin Palframan, said: "This is a huge step forward. Kadcyla has been shown to extend life by up to six months in HER2-positive secondary breast cancer patients, and with more manageable side effects than alternative drugs.

See Also:
New Drug 'Could Stop Breast Cancer Spread', Claim Scientists
Breast Cancer: Expert Reveals How Alcohol And Exercise Play A Massive Role In Cancer Prevention

"It has the potential to provide women with a better quality of life in their final months than existing treatments, which could make a significant difference.

"A thousand women die from metastatic, or secondary, breast cancer every month in the UK and this treatment has the potential to provide some of them not only with additional time, but importantly, quality time to spend with their friends and families.

"Whilst we are very pleased that this new treatment will now be made available on the cancer drugs fund throughout England, it's important to point out that this fund is only guaranteed until 2016.

LIKE HUFFPOST UK LIFESTYLE ON FACEBOOK | FOLLOW US ON TWITTER

"We strongly believe that a permanent, sustainable process by which drugs like this are made available to patients across England on a long-term basis is desperately needed."

Mia Rosenblatt, head of policy and campaigns at Breast Cancer Campaign, said: "Today's announcement that this revolutionary new drug is now available to patients with advanced HER2-positive breast cancer (around 20% of those with breast cancer), is really encouraging news, as it has been shown to extend life by up to six months and have more manageable side effects than other existing treatments."

She said secondary breast cancer is not curable, "so it is essential that better treatments are developed and made available to extend the quality of life and time these patients have with their families".

She added: "We look forward to the assessments by Nice and the Scottish Medicines Consortium (SMC) to ensure that all patients who could benefit from this drug are able to receive it over the long term."

Related

Healthy Living Health News Women Breast Cancer uk lifestyle news breast cancer treatment

Suggest a correction

|